Tanzania - English - Tanzania Medicinces & Medical Devices Authority

lincoln pharmaceuticals limited, india - paracetamol, phenylephrine hydrochloride, chlorpheamine maleate , caffeine as anhydrous - tablets - paracetamol 500 mg phenylephrine hydrochloride 5 mg chlorpheniramine maleate 2 mg caffeine anhydrous 30 mg

Namibia - English - Namibia Medicines Regulatory Council

pharmacare limited - ascorbic acid 75 mg, ; caffeine 30 mg, ; chlorpheniramine maleate 2 mg, ; paracetamol 300 mg - capsule - each capsule contains: ; ascorbic acid 75 mg, ; caffeine 30 mg, ; chlorpheniramine maleate 2 mg, ; paracetamol 300 mg

Israel - English - Ministry of Health

teva israel ltd - caffeine; chlorpheniramine maleate; paracetamol; phenylephrine hydrochloride - caplets - paracetamol 300 mg; chlorpheniramine maleate 2 mg; phenylephrine hydrochloride 10 mg; caffeine 30 mg - phenylephrine, combinations - phenylephrine, combinations - symptomatic relief of common cold, congestion associated with sinusitis, allergic rhinitis accompanied by fever and pain.

Israel - English - Ministry of Health

teva israel ltd - caffeine anhydrous; chlorpheniramine maleate; paracetamol; phenylephrine hydrochloride - tablets - paracetamol 300 mg; chlorpheniramine maleate 2.0 mg; phenylephrine hydrochloride 10 mg; caffeine anhydrous 30 mg - phenylephrine, combinations - symptomatic relief of common cold, congestion associated with sinusitis, allergic rhinitis accompanied by fever and pain.

United States - English - NLM (National Library of Medicine)

fresenius kabi usa, llc - caffeine citrate (unii: u26eo4675q) (caffeine - unii:3g6a5w338e) - caffeine citrate 20 mg in 1 ml - caffeine citrate oral solution is indicated for the short term treatment of apnea of prematurity in infants between 28 and <33 weeks gestational age. caffeine citrate is contraindicated in patients who have demonstrated hypersensitivity to any of its components.

Uganda - English - National Drug Authority

regal pharma u limited; regal pharma u limited - chlorpheniramine maleate+ paracetamol+ caffeine anhydrous+ phenylephrine hcl - oral solid ordinary capsules - 2mg+500 mg+30 mg+5mg

United States - English - NLM (National Library of Medicine)

auromedics pharma llc - caffeine citrate (unii: u26eo4675q) (caffeine - unii:3g6a5w338e) - caffeine citrate 20 mg in 1 ml - caffeine citrate injection, usp is indicated for the treatment of apnea of prematurity. caffeine citrate injection is contraindicated in patients who have demonstrated hypersensitivity to any of its components.

United States - English - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - caffeine citrate (unii: u26eo4675q) (caffeine - unii:3g6a5w338e) - caffeine citrate 20 mg in 1 ml - caffeine citrate injection is indicated for the treatment of apnea of prematurity. caffeine citrate injection is contraindicated in patients who have demonstrated hypersensitivity to any of its components.

United States - English - NLM (National Library of Medicine)

sagent pharmaceuticals - caffeine citrate (unii: u26eo4675q) (caffeine - unii:3g6a5w338e) - caffeine citrate 20 mg in 1 ml - caffeine citrate is indicated for the treatment of apnea of prematurity. caffeine citrate is contraindicated in patients who have demonstrated hypersensitivity to any of its components.

United States - English - NLM (National Library of Medicine)

fresenius kabi usa, llc - caffeine citrate (unii: u26eo4675q) (caffeine - unii:3g6a5w338e) - caffeine citrate 20 mg in 1 ml - caffeine citrate injection is indicated for the treatment of apnea of prematurity. caffeine citrate is contraindicated in patients who have demonstrated hypersensitivity to any of its components.